AC

Ashish Chopda

Active Director Director DIN 00903764
DIN 00903764 First appointment Dec 1994 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Dec 1994
Shareholding value •••• Premium profile

About Ashish Chopda

Data last updated:

Ashish Chopda is a Director at Rishabh Laboratories Pvt Ltd (since 1994), Director at Regalis Life Sciences Private Limited (since 2019) and Director at Aspire Pharmaceuticals Private Limited (since 2020), and holds 1 more current directorship. The companies operate in Healthcare and Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹45.29 Cr; the largest is Rishabh Laboratories Pvt Ltd at ₹44.75 Cr (FY 2025). Earlier, Ashish Chopda was a Director at Infinito Cables Private Limited (from 2020) and Director at Healworth Life Sciences Private Limited (from 2008).

DIN 00903764
Primary Designation Director
Industry Healthcare
First Appointment 01 Dec 1994
Oldest Company Age 32 yrs
Largest company Rishabh Laboratories Pvt Ltd · ₹44.75 Cr (FY 2025)
Combined revenue ₹45.29 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rishabh Laboratories Pvt Ltd U24232CT1994PTC008039
Director01 Dec 19941994₹44.75 Cr (FY 2025)Active
Director12 Oct 20192016₹51.5 Lakh (FY 2025)Active
Director12 Nov 20202020₹2.5 Lakh (FY 2025)Active
Director15 May 20252025Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Infinito Cables Private Limited U25190CT2020PTC010565
Director10 Sep 20202020Strike Off
Director08 Jul 20082008Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aspire Pharmaceuticals Private Limited
Rishabh Laboratories Pvt Ltd
Regalis Life Sciences Private Limited
Infinito Cables Private Limited
Premium access

Shareholding and investment profile for Ashish Chopda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashish Chopda

Ashish Chopda currently holds 4 directorships: Rishabh Laboratories Pvt Ltd (Director, since 01 Dec 1994, revenue ₹44.75 Cr (FY 2025)); Regalis Life Sciences Private Limited (Director, since 12 Oct 2019, revenue ₹51.5 Lakh (FY 2025)); Aspire Pharmaceuticals Private Limited (Director, since 12 Nov 2020, revenue ₹2.5 Lakh (FY 2025)); Vitalis Health Sciences Private Limited (Director, since 15 May 2025).

Ashish Chopda was first appointed on 01 Dec 1994 as Director at Rishabh Laboratories Pvt Ltd. The most recent appointment on record is 15 May 2025 at Vitalis Health Sciences Private Limited.

The 3 current companies of Ashish Chopda that report revenue have a combined latest revenue of ₹45.29 Cr: Rishabh Laboratories Pvt Ltd ₹44.75 Cr (FY 2025); Regalis Life Sciences Private Limited ₹51.5 Lakh (FY 2025); Aspire Pharmaceuticals Private Limited ₹2.5 Lakh (FY 2025).

Ashish Chopda held 2 earlier board appointments: Infinito Cables Private Limited (Director, from 10 Sep 2020); Healworth Life Sciences Private Limited (Director, from 08 Jul 2008).

The current boards of Ashish Chopda's companies include Komal Chand Chopda (Rishabh Laboratories Pvt Ltd), Pramod Devi Chopda (Rishabh Laboratories Pvt Ltd), Rishabh Chopda (Rishabh Laboratories Pvt Ltd), Navin Deshlahra (Aspire Pharmaceuticals Private Limited), Usha Sharma (Aspire Pharmaceuticals Private Limited), Yamini Nirmal Maheshwari (Aspire Pharmaceuticals Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available